Search Results
Found 4 results
510(k) Data Aggregation
(376 days)
BLT Dental Implant Systems are intended to be placed in the upper and lower jaw to support prosthetic devices and to restore a patient's chewing function. BLT Dental Implant systems are also indicated for immediate or early implantation following extraction or loss of natural teeth. Implants can be placed with immediate function on single-tooth and/or multiple tooth applications when good primary stability is achieved and with appropriate occlusal loading to restore chewing function. The prosthetic restorations used are single crowns, bridges and partial or full dentures, which are connected to the implants through the corresponding components (abutments). In cases of fully edentulous patients, 4 or more implants must be used in immediately loaded cases.
The proposed devices, BLT Dental Implant Systems, are indicated for oral endosteal implantation in the upper and lower jaw and for the functional and esthetic oral rehabilitation of edentulous and partially dentate patients. The proposed devices can also be used for immediate or early implantation following extraction or loss of natural teeth. The proposed device contains dental implant, healing cap and abutment. The dental implant system is available in two types, NC type and RC type.
The request asks for acceptance criteria and details of the study proving these criteria are met. The provided text is a 510(k) Summary for a dental implant system. This type of submission focuses on demonstrating substantial equivalence to a predicate device, primarily through non-clinical testing and comparison of characteristics, rather than a clinical study with detailed acceptance criteria and performance metrics typically found for AI/ML devices. Therefore, much of the requested information (like effect size, ground truth, sample size for training/test sets, expert qualifications, and adjudication methods) is not applicable or unavailable from this document.
However, I can extract information related to the device's performance based on non-clinical testing and the acceptance criteria implicitly defined by compliance with recognized standards and demonstrated equivalence to the predicate device.
Here's the summary based on the provided document:
Acceptance Criteria and Study Details for BLT Dental Implant System (K212364)
The "acceptance criteria" for this device are implicitly defined by its compliance with various ISO and ASTM standards, and its demonstrated substantial equivalence to a legally marketed predicate device (K150388) and several reference devices. The "study" proving these criteria is a series of non-clinical tests and a comparison of technological characteristics.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria Category | Specific Criteria (Implicit via Standards/Equivalence) | Reported Device Performance | Study that Proves this Performance |
---|---|---|---|
Mechanical Performance | No significant difference in dynamic fatigue performance compared to predicate device. (Aligned with ISO 14801) | "The test result does not show any significant difference." (between proposed device and predicate) | Mechanical test performed according to FDA guidance and ISO 14801. |
Biocompatibility | Materials are biocompatible and do not cause adverse effects. (Aligned with ISO 10993 standards) | "The subject device is as safe... as the legally marketed predicate device..." as materials are identical to previously cleared device (K192274). | Leveraged prior biocompatibility testing for K192274, as materials are identical in formulation, processing, and sterilization. Formal compliance with ISO 10993-1, -5, -10, -11 mentioned. |
Sterilization | Achieves a Sterility Assurance Level (SAL) of $10^{-6}$. Maintain package integrity. (Aligned with ISO 11137-2) | "Sterilized by irradiation to achieve a SAL of $10^{-6}$." "Vaccuum leak test and sterility test were provided to verify the package integrity." | Sterilization method validated in accordance with ISO 11137-2. Package process is the same as K150388. Complies with ISO 11137-1, ISO 11607-1, -2, ASTM D3078-02(2013), ASTM F88/F88M-15, ASTM F1886/F1886M-16, ASTM F1929-15, ASTM F2096-11. |
Material Composition | Complies with relevant material specifications (Titanium alloys). | Made of Pure Titanium (for implant), Titanium Alloy (for abutment/healing cap). Meets ASTM F136-13, ASTM F67-13. | Chemical analysis leveraged from K150388 as surface modification is the same. Test reports for ASTM standards cited. |
Bacterial Endotoxin | Meets bacterial endotoxin limits. | "Bacteria endotoxin limit were evaluated for the each lot device." | USP Bacterial Endotoxin Test. |
Packaging | Packaging integrity for sterile barrier systems. | Packaging system maintains sterility. | Complies with ISO 11607-1:2019, ISO 11607-2:2019, ASTM D3078-02(2013), ASTM F88/F88M-15, ASTM F1886/F1886M-16, ASTM F1929-15, ASTM F2096-11 (Reapproved 2019), ASTM F1980-07(2011). |
Shelf Life | 5 years. | 5 years. | (Details not explicitly stated in document, but assumed based on predicate equivalence and compliance with accelerated aging standards like ASTM F1980-07(2011) related to packaging.) |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not explicitly stated for specific non-clinical tests. Non-clinical tests like mechanical testing (ISO 14801) typically involve a specific number of samples for destructive testing, but the exact count isn't provided in the summary.
- Data Provenance: The tests were conducted by the manufacturer, Bio Concept Co., Ltd. and leverage data from previously cleared devices where materials or processes are identical. The document does not specify the country of origin of the raw test data (e.g., where the mechanical tests were physically performed) beyond the manufacturer's location in China. The data is retrospective in the sense that prior clearance data (K192274, K150388) is referenced for aspects like biocompatibility and surface analysis.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
- This is not applicable as this is a non-clinical submission for a physical medical device (dental implant system), not an AI/ML device relying on expert-annotated ground truth. The "ground truth" for non-clinical tests comes from physical measurements against established standards.
4. Adjudication Method for the Test Set
- Not applicable as this is a non-clinical submission for a physical medical device.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not applicable. This device is a physical dental implant system, not an AI/ML device, so no MRMC study was performed.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Not applicable. This is a physical device, not an algorithm.
7. The Type of Ground Truth Used
- The "ground truth" for establishing device performance in this context is derived from:
- Scientific Standards: Compliance with recognized international and national standards (ISO 14801 for mechanical properties, ISO 10993 for biocompatibility, ISO 11137-2 for sterilization, ASTM standards for materials and packaging).
- Predicate Device Equivalence: Direct comparison of technological characteristics, materials, and intended use to an existing legally marketed device (K150388) and numerous reference devices.
- Laboratory Testing: Results from mechanical tests, sterilization validation, bacterial endotoxin tests, and packaging integrity tests.
8. The Sample Size for the Training Set
- Not applicable. This is a physical device, not an AI/ML model that requires a training set.
9. How the Ground Truth for the Training Set Was Established
- Not applicable.
Ask a specific question about this device
(216 days)
The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices, such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. The Neodent Implant System - Temporary Abutments are indicated to be used on Neodent implants to provide temporary support for prosthesis structure for up to 6 months.
- Temporary Abutment for provisional restoration employed for up to 6 months;
- Intended for single use;
- Provided sterile via ethylene oxide gas;
- Constructed of titanium alloy (Ti6Al4v-ELI) per ASTM F136;
- Coronal geometry has grooves to facilitate bonding of acrylic material;
- Abutment is screw-retained;
- Coronal geometry contains channels to facilitate reduction of abutment height;
- Provided in anti-rotational and rotational versions supporting single and multi-unit restorations, respectively;
- Provided in multiple gingival heights;
- Implant-to-abutment interface compatible with GM implants of the Neodent Implant System.
Here is the information about the acceptance criteria and the study that proves the device meets them, based on the provided text:
1. Table of Acceptance Criteria & Reported Device Performance:
The document doesn't explicitly state quantitative acceptance criteria for device performance in a table format. Instead, it refers to performance data used to demonstrate substantial equivalence to a predicate device. The performance data is therefore related to demonstrating features or durability comparable to established standards and the predicate.
Performance Characteristic | Acceptance Criteria (Implicit) | Reported Device Performance |
---|---|---|
Fatigue Strength | Sufficient to withstand dynamic loading in the oral environment, demonstrating equivalence per ISO 14801 guidelines for worst-case implant construct with temporary abutments for multi-unit restorations. | Dynamic fatigue test per ISO 14801 was performed to determine the fatigue strength for the worst-case implant construct assembled with GM Temporary Abutments for multi-unit restorations, according to FDA Guidance. (Specific numerical result not provided, but implies satisfactory performance to demonstrate equivalence). |
Torsional Strength | Sufficient to withstand static torsional loading for abutment screws. | Torsion testing was performed to evaluate the GM Temporary Abutments Screws under static torsional loading. (Specific numerical result not provided, but implies satisfactory performance to demonstrate equivalence). |
Sterility | Sterility Assurance Level (SAL) of 1 x 10^-6 via ethylene oxide gas. | Sterilization of the subject abutments via ethylene oxide gas using the overkill method has been validated according to the requirements of ISO 1135. A minimum Sterility Assurance Level (SAL) of 1 x 10^-6 has been validated. |
Ethylene oxide residuals have been assessed per ISO 10993-7. Residuals are within accepted limits. | ||
Shelf Life | At least 5 years. | Accelerated and Real Time Aging tests were performed according to ASTM F1980. The Shelf Life of the subject devices is 5-years. |
Biocompatibility | Biologically safe for temporary use in the human body. | Biological Safety Assessment guided by ISO 10993-1. |
Cytotoxicity testing was performed per ISO 10993-5. | ||
Chemical characterization was performed per ISO 10993-18. | ||
Biocompatibility sample preparation was performed per ISO 10993-12. (Implies positive results showing biocompatibility and absence of cytotoxity within accepted limits). |
2. Sample Size Used for the Test Set and Data Provenance:
The document does not specify the exact sample sizes for each of the tests (dynamic fatigue, torsion, sterility, aging, biocompatibility). It only states that the tests were performed.
The data provenance is from JJGC Indústria e Comércio de Materiais Dentários SA (dba Neodent) located in Curitiba, Parana, Brazil. The studies are prospective in nature, as they involve performing tests and gathering data specifically for this submission.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
This information is not applicable as the studies described are performance tests (mechanical, sterilization, aging, biocompatibility) of a medical device, not diagnostic studies that require expert interpretation of results to establish ground truth (e.g., image interpretation by radiologists). The "ground truth" here is defined by objective physical and chemical standards (e.g., ISO and ASTM standards).
4. Adjudication Method for the Test Set:
This information is not applicable for the type of studies presented. Adjudication methods (like 2+1, 3+1) are typically used in clinical trials or studies where human interpretation of data is involved and discrepancies need to be resolved. The described studies are objective laboratory/engineering tests.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done:
No, a Multi Reader Multi Case (MRMC) comparative effectiveness study was not performed. This type of study is typically conducted for diagnostic devices (e.g., AI in radiology) to assess the impact of AI on human reader performance. The device described (Temporary Abutments) is a physical implant component, not a diagnostic AI tool.
6. If a Standalone (Algorithm Only Without Human-in-the Loop Performance) Was Done:
This question is not applicable as the device is a physical medical device (temporary abutment), not an algorithm or AI system. Therefore, "standalone" performance in the context of an algorithm is not relevant. The performance studies conducted (fatigue, torsion, sterility, etc.) are inherently "standalone" in that they test the device itself.
7. The Type of Ground Truth Used:
The "ground truth" for the performance studies is established by objective technical standards and regulatory guidelines. This includes:
- ISO 14801 for dynamic fatigue.
- ISO 1135 for sterilization validation.
- ISO 10993-7 for ethylene oxide residuals.
- ASTM F1980 for accelerated and real-time aging.
- ISO 10993-1, 10993-5, 10993-18, 10993-12 for biocompatibility.
- FDA Guidance documents for specific test methodologies.
The "ground truth" is adherence to and performance within the limits or specifications set by these recognized standards to ensure safety and effectiveness comparable to legally marketed predicate devices.
8. The Sample Size for the Training Set:
This information is not applicable. The device is a physical medical device, not an AI model or algorithm that requires a "training set" of data.
9. How the Ground Truth for the Training Set Was Established:
This information is not applicable for the same reason as above; there is no "training set" for physical device performance.
Ask a specific question about this device
(159 days)
Straumann® BLX Implants are suitable for endosteal implantation in the upper and lower jaw and for the functional and esthetic oral rehabilitation of edentulous and partially edentulous patients. BLX Implants can be placed with immediate function on single-tooth applications when good primary stability is achieved and with appropriate occlusal loading to restore chewing function. The prosthetic restorations are connected to the implants through the corresponding abutment components.
Straumann® Closure Caps and Healing Abutments are indicated to be placed in the patient's mouth at the end of the implant placement to protect the inner configuration of the implant and to shape, maintain and stabilize the soft tissue during the healing process. Closure caps and healing abutments should be used only with suitable implant connections. Straumann Closure Caps and Healing Abutments have a maximum duration of usage of 6 months.
Prosthetic components directly or indirectly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they may not be placed into occlusion. Final abutments may be placed into occlusion when the implant is fully osseointegrated. BLX Temporary Abutments have a maximum duration of usage of 180 days.
Straumann® Variobase® prosthetic components directly or indirectly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. The prosthetic restoration (crowns) can be cemented onto the Straumann® Variobase® prosthetic components. A temporary restoration can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they must be placed out of occlusion. Final abutments and restorations may be placed into occlusion when the implant is fully osseointegrated. All digitally designed copings and/or crowns for use with the Straumann® Variobase® Abutment system are intended to be sent to Straumann for manufacture at a validated milling center.
The Straumann BLX Implants are fully tapered implants manufactured utilizing the Roxolid material and are finished with SLActive® surface. The connection is identified as conical fitting with Torx style engaging feature. The prosthetic platforms are identified as RB (Regular Base) and WB (Wide Base). The implants with a RB platform have a "small top/head", and implants with WB platform have a "large top/head", whereas the internal connection is identical for both platform and all the implant diameters and lengths.
The closure cap and healing abutments are manufactured from Titanium Grade 4, per ISO 5832-2 and ISO 5832-11, and are anodized signal violet for the parts compatible with the RB platform and brown for the parts compatible with the WB platform for identification purposes. Closure caps are screwed into the implant to protect the inner configuration and shoulder of the implant during the healing phase in cases of submerged (submucosal) healing. Healing abutments are screwed into the implant to protect the inner configuration in cases of transmucosal healing and are placed out of occlusion.
The temporary abutments are manufactured from TAN and are anodized signal violet (RB platform) and brown (WB platform) for identification purposes. The temporary abutments are fixed in the implant with a basal screw which is also manufactured from TAN. The basal screw will be delivered with the temporary abutment.
BLX Variobase abutments is a two-piece abutment ultimately composed by three components: Variobase™ Abutment (Ti-base), Prosthetic restoration (coping and/or crown), and Basal Screw. The BLX Variobase Abutments are manufactured and are delivered with the corresponding basal screw. The prosthetic restoration (crowns) can be cemented onto the Variobase prosthetic components.
Basal screws are used to seat the temporary abutments and the BLX Variobase Abutments to the dental implant, and can be also be used during lab procedures to fix lab prosthetic parts on implant analogs. There is one basal screw for the RB platform and one for the WB platform. They have identical designs and differ only in color-coding (signal violet and brown) to ease the handling. They are provided along the abutments but they are also provided as standalone screws. The BLX basal screws are manufactured from TAN.
This document describes the Straumann® BLX Implant System, a dental implant system, and its various components. The information provided is for a 510(k) premarket notification to the FDA. The goal is to demonstrate substantial equivalence to legally marketed predicate devices.
Here's an analysis of the acceptance criteria and study information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The provided document is a 510(k) summary, which focuses on demonstrating substantial equivalence to predicate devices rather than setting and meeting specific, quantitative acceptance criteria for novel performance. Instead, the "acceptance criteria" are implied by successful comparative testing and adherence to existing standards and guidance documents. The "reported device performance" is the outcome of these tests.
Test Type | Implied Acceptance Criteria (Demonstrated by Equivalence/Compliance) | Reported Device Performance |
---|---|---|
Sterilization Validation | Achieves a Sterility Assurance Level (SAL) of 10⁻⁶ via gamma irradiation. Complies with ISO 11137-1:2006 and ISO 11137-2:2013. For end-user sterilized components, validation according to ISO 17665-1, ISO 17665-2, and FDA guidance "Reprocessing Medical Devices in Health Care Settings." | BLX implants, closure caps, and healing abutments are sterile via gamma irradiation (25 kGy minimum), validated to SAL 10⁻⁶ per ISO 11137-1:2006 and ISO 11137-2:2013 (overkill bioburden method). BLX Temporary Abutments and BLX Variobase Abutments are end-user sterilized by moist heat (steam), validated per ISO 17665-1, ISO 17665-2, and FDA reprocessing guidance. |
Shelf Life | Packaging ensures maintaining sterility for a specified period and materials are not adversely affected. | Shelf life for sterile devices remains 5 years, as packaging is equivalent to predicate/reference devices and materials are not adversely affected by time. |
Pyrogenicity | Meets pyrogen limit specifications based on LAL Endotoxin Analysis (e.g., |
Ask a specific question about this device
(142 days)
Straumann® Bone Level Tapered Implants Ø2.9 mm are indicated for oral endosteal implantation in the upper and lower jaw and for the functional and aesthetic oral rehabilitation of patients with missing teeth. Straumann® Bone Level Tapered Implants 02,9 mm can also be used for immediate or early implantation following extraction or loss of natural teeth. Implants can be placed with immediate function on single-tooth applications when good primary stability is achieved and with appropriate occlusal loading to restore chewing function. The prosthetic restorations are connected to the implants through the corresponding components (abutments).
The Straumann® Bone Level Tapered Implants 02.9 mm are indicated for reconstruction of missing incisors in the lower jaw and lateral incisors in the upper jaw.
Straumann® Closure Caps and Healing Abutments are indicated to be placed in the dental implant after placement in the patient's jaw to protect the inner configuration of the implant and stabilize the soft tissue during the healing process. Closure Caps and Healing Abutments should be used only with the corresponding implant comection.
Straumann® SC Temporary Abutments are indicated for use as an aid in prosthetic rehabilitations. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase. Strauman® SC Temporary Abutments have a maximum duration of usage of 180 days.
Straumann® SC Variobase® abutments are indicated for use as an aid in prosthetic rehabilitations. The prosthetic restoration can be cemented on the Straumann® SC Variobase® prosthetic components. A temporary restoration can be used prior to the insertion of the final components to maintain, stabilize and form the healing phase. Final abutments and restorations may be placed into occlusion when is fully osseointegrated. All digitally designed copings and/or crowns for use with the Straumann® Variobase® Abutment system are intended to be sent to Straumann for manufacture at a validated milling center.
Straumann® SC CARES® abutments are indicated for single-tooth replacements and multiple tooth restorations. The prosthetic restoration can be cemented or directly veneered/screw-retained.
The Straumann Ø2.9mm Bone Level Tapered (BLT) Implants are apically tapered implants with an external diameter of Ø2.9 mm and lengths of 10 mm, 12 mm, and 14 mm. The implants are manufactured utilizing the Roxolid material and are finished with either the SLA® or SLActive® surface. The prosthetic platform is identified as SC (Small CrossFit®) which corresponds to a shoulder diameter of Ø2.9 mm.
The closure cap and healing abutments are manufactured from Titanium Grade 4 and are anodized blue for identification purposes. The closure cap is conical and has a height of 0.5 mm. The healing abutments are seated in the implant with a basal screw which is manufactured from TAN. The healing abutments are oval in shape and are available in four different heights ranging between 2.0 mm and 6.5 mm.
The temporary abutments are manufactured from TAN and are anodized blue for identification purposes. The temporary abutments are oval in shape in order to accommodate narrow interdental spaces and are available with three different gingival heights ranging between 1.0 mm and 3.0 mm. The temporary abutments are seated in the implant with a basal screw which is also manufactured from TAN.
There are three components to the Straumann® SC Variobase™ Abutments:
- Straumann® SC Variobase™ Abutments (Ti-base)
- Prosthetic restoration (coping and/or crown)
- Basal Screw
The Straumann® SC Variobase® Abutments are manufactured from TAN. The abutments are oval in shape to accommodate narrow interdental spaces and are available with three different gingival heights ranging between 1.0 mm and 3.0 mm. The abutments will be delivered with the corresponding basal screw.
The following is an overview of the possible prosthetic restoration (coping and/or crown) materials:
- Cast materials:
- Type 4 metals (ISO 22674)
- Base metal alloys (e.g., cobalt-chromium (CoCr))
- Noble metal alloys (e.g., gold alloy)
- Press materials:
- IPS e.max® Press Ceramic (K120053)
- Digital materials:
- coron®
- zerion® LT
- polycon® ae
All digitally designed copings and/or crowns for use with the Straumann® Variobase® Abutment system are intended to be sent to Straumann for manufacture at a validated milling center.
The Straumann® SC CARES® Abutments are customized abutments manufactured from TAN. The abutments are designed by the customer by scanning the intraoral situation and designing of the shape with the CAD module of the integrated software. The design data is then sent to Straumann where the fabrication of the customized abutment is performed. The TAN alloy is capable of being directly veneered once the abutment is subject to a heat treatment step by the dental laboratory technician. A finished crown may also be cemented to the subject abutments rather than by direct veneer. The abutments will be delivered with the corresponding basal screw.
The provided document (K162890) describes the regulatory submission for Straumann dental implants and associated components. However, it does not contain information about studies proving the device meets acceptance criteria for performance metrics related to diagnostic accuracy, such as sensitivity, specificity, or AUC, as these types of metrics are typically associated with diagnostic or AI-powered devices.
Instead, the document focuses on demonstrating substantial equivalence to existing legally marketed predicate devices through various non-clinical tests. The "acceptance criteria" here relate to the successful completion of these engineering and safety tests, rather than clinical performance metrics for diagnostic capability.
Therefore, the requested information cannot be fully provided in the format desired for diagnostic devices because this submission deals with dental implants, not a diagnostic AI.
However, I can extract the information related to the performance testing that was conducted to support the substantial equivalence claim.
Acceptance Criteria and Device Performance (Not applicable in the typical sense for diagnostic AI):
The document does not present acceptance criteria or reported device performance in terms of diagnostic accuracy metrics (e.g., sensitivity, specificity, AUC) because the devices (dental implants and abutments) are not diagnostic AI devices. Instead, the "performance testing" focuses on engineering, biocompatibility, and sterilization validations to demonstrate substantial equivalence to predicate devices.
Summary of Performance Testing Conducted (which can be seen as meeting "acceptance criteria" for safety and efficacy in this context):
-
Sterilization Validation (Section 5.8.1):
- Acceptance Criteria: Validation according to applicable recommendations in the FDA guidance document "Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling, issued on March 17, 2015".
- Reported Device Performance: The sterilization process for SC Temporary Abutments, SC Variobase Abutments, and SC CARES Abutments was validated.
-
Biocompatibility Testing (Section 5.8.2):
- Acceptance Criteria: Compliance with ISO 10993-1:2009 and the FDA Guidance document "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process', Guidance for Industry and Food and Drug Administration Staff, Document issued on: June 16, 2016". The subject devices should have identical nature of body contact, contact duration, material formulation, manufacturing processes, and sterilization methods compared to predicate devices, raising no new biocompatibility issues.
- Reported Device Performance: The subject devices have identical biocompatibility characteristics to the primary and reference predicate devices. Therefore, no additional biocompatibility testing was required or performed.
-
Software Verification and Validation Testing (Section 5.8.3): (Applicable to CARES Visual software for abutment design, which is part of the manufacturing process, not a diagnostic AI)
- Acceptance Criteria: Compliance with FDA guidance documents "Class II Special Controls Guidance Document: Optical Impression Systems for Computer Assisted Design and Manufacturing (CAD/CAM) of Dental Restorations" and "General Principles of Software Validation; Final Guidance for Industry and FDA Staff".
- Reported Device Performance: Software verification and validation testing were conducted; the software for the device (CARES Visual) was considered a "moderate" level of concern.
-
Bench Testing (Section 5.8.4):
- Acceptance Criteria: Compliance with the FDA guidance document "Guidance for Industry and FDA Staff – Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments" for dynamic fatigue, static strength, and insertion torque tests.
- Reported Device Performance: Dynamic fatigue, static strength, and insertion torque tests demonstrated the Straumann® Ø2.9 mm Bone Level Tapered implants, SC Temporary Abutments, SC Variobase Abutments, and SC CARES abutments are equivalent to the predicate and reference devices.
Regarding the specific questions about diagnostic AI studies:
- A table of acceptance criteria and the reported device performance: As explained above, not applicable for diagnostic metrics. The performance relates to engineering and safety tests.
- Sample size used for the test set and the data provenance: Not applicable. The "tests" mentioned are non-clinical engineering and bench tests, not studies on patient data for diagnostic evaluation.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable, as there is no diagnostic test set or ground truth in this context.
- Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable.
- If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable, as this is not an AI-assisted diagnostic device.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable.
- The type of ground truth used (expert consensus, pathology, outcomes data, etc.): Not applicable to a diagnostic AI scenario. The "ground truth" for the bench tests would be the established engineering standards and physical properties of the materials.
- The sample size for the training set: Not applicable, as there is no AI training set.
- How the ground truth for the training set was established: Not applicable.
Ask a specific question about this device
Page 1 of 1